Paul F. Reid

No open positions remaining

62 year

Health Technology

Consumer Services

Profile

Paul F.
Reid was the founder of ReceptoPharm, Inc. founded in 2001, where he held the title of Chief Executive Officer from 2009 to 2011.
He was also the Chief Executive Officer of Nutra Pharma Corp.
from 2008 to 2010 and held the title of Head-Scientific Affairs at Biotherapeutics, Inc. in 1993.
Dr. Reid obtained a doctorate degree from Imperial College London and an undergraduate degree from Trinity College Dublin in 1987.

Former positions of Paul F. Reid

Companies	Position	End
NUTRA PHARMA CORP.	President	2009-11-17
Biotherapeutics, Inc. Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes	Corporate Officer/Principal	1992-12-31
ReceptoPharm, Inc. ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary therapeutic protein products	Chief Executive Officer	-

See the detail of Paul F. Reid's experience

Training of Paul F. Reid

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul F. Reid's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Nutra Pharma Corp. Nutra Pharma Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treat pain, autoimmune disorders, viral diseases	Health Technology
Imperial College London Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ReceptoPharm, Inc. ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary therapeutic protein products	Health Technology
Trinity College Dublin Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Biotherapeutics, Inc. Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes	Health Technology